TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
MIRM

Mirum Pharmaceuticals Inc

Healthcare · Biotechnology

89.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Mirum Pharmaceuticals Inc (MIRM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,045 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MIRM
Line item Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 52 52 104 158 147 173 156 142 241 222 248 235 295 278 297 364 353 334 444 651 647 652 661 668 671 690 726 785 843 891 1,045
– 52 50 85 129 119 162 152 138 236 218 228 197 167 155 147 216 190 172 384 389 388 389 368 387 393 411 453 531 550 569 636
– 52 49 42 31 12 72 83 49 142 91 92 56 31 46 55 36 28 49 297 303 286 303 233 223 223 212 228 282 297 325 331
– 52 49 84 126 117 160 149 134 232 213 224 190 157 140 125 185 152 132 330 306 286 303 278 284 280 278 305 376 383 386 438
– – 0.0 – – – – – – – – 1.0 0.4 4.4 9.1 13 16 24 25 35 48 68 55 60 69 78 96 107 107 123 133 145
– – 0.0 – – – – – – – – – – 1.5 1.6 4.5 6.9 5.6 6.6 8.5 22 22 22 20 22 22 22 23 24 25 26 26
– – 1.3 1.4 1.6 3.7 3.7 3.5 3.4 1.3 1.2 2.9 1.1 1.0 0.9 0.8 0.8 0.9 0.9 0.9 2.2 – – – – – – – – – – –
– – 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – 0.0 – – – – – – – – – 19 19 18 46 45 59 58 56 258 253 257 262 256 250 244 238 232 261 254 247
– 2.4 68 132 12 16 17 20 22 69 88 152 179 174 169 187 195 211 192 365 382 398 417 432 436 445 457 471 493 528 648 1,055
– 2.4 6.5 11 11 13 14 17 19 18 35 29 50 43 35 45 51 65 49 58 75 87 106 112 116 127 128 145 160 206 273 223
– – 0.1 0.2 0.3 0.4 0.5 0.5 0.6 0.6 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.1 1.1 1.1 0.4 1.1 1.5 1.7 1.6 2.1 2.0 2.1 2.4 –
– 0.3 2.4 2.3 2.7 3.4 3.3 3.0 5.2 3.2 5.7 5.4 5.0 9.2 4.9 8.1 11 8.7 6.4 14 7.4 7.4 16 9.8 9.5 15 12 18 12 9.6 59 23
– – 1.2 – – – – – – – – – – – – – – – – 306 306 306 307 307 308 308 309 309 309 310 310 750
– 43 -16 -28 146 130 156 136 120 172 134 96 56 120 109 111 169 142 141 79 269 249 235 229 232 226 233 255 292 315 242 -10
– -17 -23 -37 -52 -70 -91 -114 -136 -173 -224 -268 -315 -257 -294 -321 -356 -393 -423 -497 -521 -556 -582 -606 -620 -644 -659 -665 -662 -668 -1,458 -1,525
10 2.7 10 23 18 23 25 25 25 26 30 30 30 31 31 32 35 38 38 38 41 47 47 47 48 48 49 50 57 50 59 63

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?